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Abstract
Portable x-ray fluorescence (XRF) devices have grown in popularity for possible metal exposure 
assessment using in vivo measurements of bone and toenail. These measurements are 
accompanied by a small radiation dose, which is typically assessed by radiation safety committees 
to be minimal. However, an understanding of precise dose under different instrument conditions is 
still needed. This study set out to do a thorough investigation of the exact dose measurements 
using optically stimulated dosimeters, thermoluminescent dosimeters, and simulation with Monte 
Carlo N-particle transport code to assess the skin and total body effective dose typical of portable 
XRF devices. We showed normal linear relationships between measurement time, x-ray tube 
current, and radiation dose with the device, and showed a second order polynomial relationship 
with increasing voltage and radiation dose. Dose was quantified using TLD, OSLD, and 
simulations, which gave similar dose estimations. Skin dose for a standard 50 kV 40 uA 
measurement for bone and toenail in vivo was 48.5 and 28.7 mSv according to simulation results. 
Total body effective dose was shown as 3.4 and 2.0 uSv for in vivo bone and toenail measurements 
for adults using the portable XRF device.
Introduction
Portable x-ray fluorescence (XRF) devices are being used more frequently for in vivo 
measurements to assess metal exposures in populations. The risks associated with the 
radiation exposure of these low energy x-ray tubes are minimal, but since they are used in 
population studies, a more thorough review of the radiation exposure would be appropriate 
to fully consider the radiation exposures associated with the use of portable x-ray 
fluorescence devices.
Metal exposure assessment has been performed for decades using x-ray fluorescence. 
Previous devices for x-ray fluorescence measurements used radioisotopes as a source to 
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stimulate the characteristic x-ray emissions (Chettle, Scott, & Somervaille, 1991). 
Particularly the cadmium-109 radioisotope K-shell XRF device for lead measurement had 
well characterized radiation dose, which was summarized in a previous study (Huiling Nie, 
Chettle, Luo, & O’Meara, 2007). The radiation dose associated with portable XRF 
measurements has not been characterized as accurately and thoroughly. Only one previous 
study has explored the radiation dose of measurements using thermoluminescent dosimeters 
(H. Nie et al., 2011). However, it was quickly found after optimization of the device that the 
x-ray tube current used for this measurement was not optimal, and changes in x-ray tube 
settings were proposed for future studies and further changes are likely in the future to 
optimize for different metal or tissue measurements (Aaron James Specht, Weisskopf, & 
Nie, 2014).
Portable XRF presents a unique problem since the device uses a modifiable source, which 
can be used on different tissues to measure different biomarkers of exposure. Changes to the 
source or tissue examined would result in changes to the radiation dose and radiosensitive 
organs in the measurement. In this study, we measured radiation dose from a portable XRF, 
and identified the changes in dose with different x-ray tube voltage, current, and filtration 
when doing bone lead and toenail metal measurements.
2. Materials and Methods
2.1 Portable XRF Device
We used a Thermo Fisher XL3t GOLDD+ portable XRF device for this study (Thermo 
Fisher Inc., Billerica, MA). The device is typically used commercially for mining and soil 
measurements, but has been investigated for use in metal exposure assessment in vivo. This 
study focuses on in vivo uses and the associated radiation dose. This same x-ray system has 
been used in previous studies measuring bone in vivo for strontium and lead, and for 
measuring toenail in vivo for mercury and manganese (A. J. Specht et al., 2016; Aaron J. 
Specht, Mostafaei, Lin, Xu, & Nie, 2017; Aaron James Specht et al., 2014; Zhang, Specht, 
Weisskopf, Weuve, & Nie, 2017). For this study we used variable voltage, current, and filters 
from the device, which we note in the results for our measurements. The maximum power 
output of the x-ray tube was 2 watts.
2.2 Standard Phantoms
Soft tissue and bone equivalent phantoms were used in this study to determine the dose for 
in vivo bone measurements. Lucite plate phantoms were used to simulate soft tissue over 
bone by placing the Lucite under the flat surface of the bone phantoms in increments of 1 
mm up to 5 mm of Lucite thickness. These Lucite plates were found to be an acceptable 
phantom for soft tissue in our previous study (Aaron James Specht et al., 2014). Cylindrical 
phantoms with a flat base for measurements were made of plaster of Paris were used to 
simulate bone. These measurements were made from the flat base of the phantom.
Toenail phantoms were made to test in vivo measurements of toenail metals. Standard 
phantoms for toenails were made using epoxy resin with added salt to standardize the 
attenuation coefficients, similar to prior work (Roy, Gherase, & Fleming, 2010; Zhang et al., 
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2017). For the dose assessment we used toenail with 0.6 and 1.3 mm to determine the 
influence of toenail thickness on the radiation dose.
2.3 Optically Stimulated Luminescence Dosimetry System
For this study we used a Landauer InLight MicroStar Optically Stimulated Luminescence 
Dosimeter (OSLD) reader. This system has been used in studies of similar surface dose 
measurements in clinical practice (Yusof et al., 2015). The system was calibrated using 
standard OSLDs obtained from Landauer. Two calibrations were completed, one for low 
dose response (3 OSLDs between 10 and 1000 mRad), and one for high dose response (3 
OSLDs between 1 and 1500 Rad). The measurements of calibration OSLDs were made 9 
times to ensure accuracy, and it was found that there was < 2% change between readings, 
which fit the qualifications for clinical use of OSLD measurements according to TG-191 
AAPM recommendations (AAPM, 2017). The OSLDs used for dose measurements were 
found to be accurate within 10% with repeated measures of the same x-ray settings 
measurement, which is primarily due to a higher background dose present in many of the 
OSLDs. Error from these measurements are represented in the figures as a measure of the 
error identified in our repeatability tests during measurements. We used these measurements 
to get a sense of the characteristic relationships between the portable XRF radiation dose 
and different situations, and did not expect a calibration of these OSLDs to produce 
quantified results within clinical level accuracy from this study.
We measured the radiation dose from a variety of settings and setups of phantoms. We first 
used a number of different geometries with the OSLDs in order to find the maximal dose. 
We measured the dose using x-ray tube settings 50 kV, 40 uA, and an iron and silver filter 
changing the time from 0.5, 1, 2, 3, and 4 minutes. We also did tests changing the current 
from 40 uA to 30, 20, 10 uA, while keeping the other settings the same. Then doing the 
other iterations changing the voltage to 40 kV and changing the current from 50 uA to 40, 
30, 20, and 10 uA with filtration and time as constant. We did tests using aluminum and 
titanium, molybdenum and iron, and iron and silver filtration, which could prove to be useful 
for certain in vivo measurements.
Finally, we did dose measurements using 50 kV, 40 uA, and silver and iron filtration for 
bone and skin measurements. We used 0, 1, 3, and 5 mm of skin thickness to induce scatter. 
Then we used bare bone with no skin phantoms, 3mm skin with bone, and 5 mm skin with 
bone. We attempted to estimate surface bone dose by placing the OSLDs between the skin 
and bone phantom at 1, 2, 3, and 5 mm of skin. Lastly, we did tests of entrance and exit dose 
of toenail phantoms with thicknesses of 0.6 and 1.3 mm using both 50 kV 40 uA and 40 kV 
50 uA x-ray tube setting with silver and iron filtration.
2.4 Thermoluminescent Dosimeters
Thermoluminescent dosimeters (TLDs) were used in this study for further validation of the 
dose readings. TLD 700 chips were used in this study, since the dose associated with XRF is 
purely from photons. The TLDs were read using a Harshaw TLD 4000 reader (Harshaw 
Partnership, Solon, OH, USA). The TLDs were calibrated against known exposures from a 
gamma irradiator at Purdue University. A Gammacell 220 (Nordian International Inc.) 
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containing a cobalt-60 radioisotope source with known exposure rates. Each TLD used in 
this study was separately irradiated for doses of 0, 25, 50, 75, 125, 250, 500, and 1000 mR, 
which were each measured 3 times to ensure the accuracy of the TLDs. The combined 
calibration curves of the TLDs produced a line with a correlation r2 of 0.995, which gave us 
confidence in the quantification and accuracy of results obtained using these TLDs.
We first used a number of different geometries for measurement to find the maximal dose 
for the TLD measurements. The portable XRF comes standard with a camera, which can 
identify items placed in the field of view of the x-ray tube, which we used for verification of 
dosimeter placement consistency. We measured these dosimeters with x-ray tube settings of 
50 kv, 40 uA, with an iron and silver filter for 3 minutes under soft tissue and bone 
phantoms, and 40 kv, 50 uA, with an iron and silver filter for 3 minutes under toenail, Lucite 
soft tissue phantoms, and bone phantoms. Finally, we used a grid pattern of 4 TLD chips to 
average over and better recreate our normalized skin area of 1 cm2 (this approach 
approximated an area of ~0.8 cm2).
2.5 Monte Carlo Simulations
We used the Monte Carlo simulation program, Monte Carlo N-Particle transport code 
(MCNP) in our study, which was developed by Los Alamos National Lab and distributed by 
the Radiation Safety Information Computational Center. This software has recently been 
updated to more accurately depict interactions at lower energies, using its default database 
for interaction cross-sections. This includes Doppler broadening effects and all interactions 
observed in XRF. In a previous study, we validated the use of this simulation to accurately 
simulate the output from the x-ray tube of the exact portable XRF used in this study (A. J. 
Specht, Weisskopf, & Nie, 2017). There was less than 9% difference between simulated and 
experimental spectral from that study. MCNP gives us the ability to set unique materials, 
densities, geometries, and sources in order to reproduce an experimental setup, and in the 
case of this study, to reproduce the dose of in vivo measurements. Previous studies have 
similarly used MCNP to estimate dose to patients in clinical settings (Yoriyaz, Stabin, & dos 
Santos, 2001). We used the same x-ray tube simulation as our previous study, but added in 
skin, bone, or toenail based on the specifications for our study. We did simulations to 
reproduce the in vivo bone measurements, and give estimates for bone and skin dose. We 
also did simulations of toenail in vivo measurements to look at skin dose below the toenail. 
The bone and skin composition and densities were taken from ICRU-44, and the toenail 
composition was taken from Rutherford and Hawk (Rutherford & Hawk, 1907).The 
simulation included a 40 cm long leg, which was used in full for energy deposition 
measurements in the total body effective dose calculations. For skin dose, only a 1cm2 voxel 
of the skin in the maximal area of exposure was used for dose measurements. In the 
calculations of dose, we used the number of particles that would have been used in the x-ray 
tube based on the amperage and a time of 3 minutes, which should make the measurements 
equal to those with TLDs and OSLDs with 3 minute exposures.
2.6 Total Body Effective Dose Calculations
We calculated total body effective dose for the bone measurement using the simulation to get 
total skin and total surface bone dose from the simulated 40 cm long leg. For the toenail 
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measurements, we assumed the same area of exposure except with the added attenuation of 
toenail. The dose from the bone was assumed to be all surface dose, since the penetration 
depth of x-rays from the portable XRF would only be ~0.5 mm into the bone. We used a 
simulation with skin (skin thickness 5 mm) and bone tissue 40 cm in length (bone radius 
1.25 cm) to ensure we captured the full dose of any scattering that occurred. We 
approximated the total body bone surface using different values for 5-year-old, 10-year-old, 
and adult females and males. Five-year-old male and female bone area was taken from 
Specker et al. (Specker, Johannsen, Binkley, & Finn, 2001) to be 950 and 935 cm2 
respectively. For adult males and females we used a 2013 CDC report on Total Body Bone 
Area with values 1385 and 1399 cm2 for 10 year olds and 2272 and 1918 cm2 for adults 
(Looker et al., 2013). We assumed the density of bone was 1.7, 1.75, and 1.8 g cm−3 for 5-
year-old, 10-year-old, and adult, respectively, as taken from the table on page 37 of ICRP 70 
(ICRP, 1995). For skin areas we used 0.78, 1.12, and 1.90 m2 for 5-year-old, 10-year-old, 
and adult, respectively (“Basic anatomical and physiological data for use in radiological 
protection: reference values. A report of age- and gender-related differences in the 
anatomical and physiological characteristics of reference individuals. ICRP Publication 89,” 
2002). We also included a comparison of total body effective dose with different tissue 
thickness values of 1, 3, and 5 mm.
3. Results
3.1 OSLD Results
Figure 1 below shows the linear dose relationship with measurement times using 50 kV, 40 
uA, and iron and silver filtration. Figures 2, 3, and 4 show the significant non-linear 
relationship between dose and changes in voltage of the portable XRF device with constant 
40 uA and iron and silver, molybdenum and iron, and aluminum and titanium filtration. 
Figure 5 shows the linear relationship between measured dose and current keeping 40 kV 
and the iron and silver filtration constant. Finally, Figure 6 shows the relationship between 
surface bone dose and skin thickness, which decreased slightly with increasing skin 
thickness. Increasing the skin thickness over the dosimeters, which would potentially 
increase scatter, did not increase the dose measured by the OSLD. The 1 cm2 skin dose 
measurements using aluminum and titanium, molybdenum and iron, and iron and silver 
filtration at 50 kV 40uA and 3-minutes were 224.7, 49.0, and 103.7 mSv, respectively.
3.2 Thermoluminescent Dosimeter Measurements
We took measurements using TLDs to look at the radiation dose for in vivo measurements of 
toenail and bone with 2 separate measurements for each. The results for these measurements 
are summarized in Table 1 below. The average result from a grid of 4 TLD chips (~0.8 cm2 
area) arranged over the irradiated area during a bone and toenail measurement changed the 
dose to 48.8 and 43.3 mSv respectively. The differences in dose quantification are explained 
in the discussion.
3.3 Simulation Dose Measurements
We used the simulation to calculate the dose of the bone surface and skin, which would be 
the only components that would have radiation dose from in vivo measurements using the 
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portable XRF. Using this, we can then calculate total body effective dose for our 
measurements. The results for the measurements of skin dose and total body effective dose 
for bone and toenail measurements are shown in Table 2. The leg was 40 cm in length to 
capture all scatter, but for the skin dose only a 1 cm2 voxel was used to determine skin dose. 
For total body effective dose, we used energy deposition in skin and bone surface, which we 
averaged over the previously mentioned total body skin and bone surface areas to arrive at 
the final values. We assume all the dose going to the bone is surface dose, surface bone and 
skin is the only contributing factors for total body effective dose in bone measurements, and 
the skin dose is the only contributing factor to total body effective dose from the toenail 
measurements. We conservatively used female average values for 5-year-old, male for 10-
year-old, and female for adult calculations to report the highest possible dose. The 
simulation resulted in a bone dose averaged over the simulated leg (40 cm long and 1.25 cm 
radius) of 2.2, 2.2, and 2.1 mSv for 5-year-old, 10-year-old, and adult respectively. The 
simulated skin dose averaged over the total leg was 1.1 uSv. Changing the tissue thickness 
and bone surface dose resulted in a total body effective dose of 3.4, 3.7, and 4.3 uSv at 5, 3, 
and 1 mm tissue thickness respectively.
3.4 In Vivo Dose Measurement Comparisons
Table 3 shows a side-by-side comparison of the skin dose estimates made by measuring the 
dose with simulation, TLDs, and OSLD and their respective volume differences.
4. Discussion
This study determined radiation doses from using portable XRF devices for in vivo 
measurements in order to determine the suitability for such use. We found the total body 
effective dose delivered by the device in a 3-minute measurement to be reasonable and skin 
dose to be at a level higher and more concentrated than typical of diagnostic exams, but far 
from any deterministic radiation risk. We demonstrated the relationship of the radiation dose 
from the device with increasing time, amperage, and voltage in the x-ray tube, and the effect 
of different filtration on the radiation dose. Finally, we used simulations to determine and 
compare the experimental measures of skin and total body effective dose measurements.
One limitation of our experimental results from the study is accounting for slight geometry 
changes in the measurements. The x-ray tube aperture is quite small, and for this reason, it 
was potentially easy to place a TLD or OSLD in a spot that did not reflect the highest 
potential dose. To combat this issue, we initially did measurements with multiple TLDs and 
OSLDs to determine the geometry with the maximal dose. This maximal dose geometry is 
what we attempted to replicate for the other measurements as part of the study. However, it 
is hard to determine whether or not the maximal dose was captured for every measurement, 
but the simulation results would not have had this same issue.
Using our phantom measurements, we were able to identify dose distribution changes with 
skin thickness. As expected, bone dose would decrease with increasing skin thickness over 
bone, but the results show a linear relationship. Over the small thickness increases shown 
with in vivo measurements of about 5 mm, the exponential interaction with attenuation is 
approximately the same as a linear relationship. Using NIST values for the attenuation 
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coefficient of skin we can determine what the approximate dose changes should be with 
increases in skin thickness assuming a perfectly collimated beam, and at 5 mm of skin 
thickness the bone surface dose should be 65.9 mSv. We show a value of 31.4 mSv for the 
bone surface dose at 5 mm of skin thickness. This difference is likely due to the x-ray tube 
source collimation being imperfect, and the beam likely spreads over a larger area with 
increasing distance, similar to an inverse square effect.
There was an observable difference in dose quantification between TLD, OSLD, and 
simulation measurements. This is mainly attributable to the varying averaged volumes for 
the doses for each of these measurements, which is evidenced by our results using a grid of 4 
TLD’s, which gave results in line with are estimated volume changes. In the singular TLD 
and OSLD measurements, we are not averaging over a true 1 cm2 area but are measuring 
about 0.2 cm2. Since, the x-ray tube aperture of the portable XRF is actually smaller than 1 
cm2 it is likely most of the dose from entrance skin exposure of the x-rays will be more 
concentrated than this initial area limit. Another potential reason for the quantification 
differences is in the calibration procedure for TLD and OSLD measurements. The 
calibration was done on standard TLD or OSLD chips, which were under almost uniform 
exposure. Since the dose from the portable XRF is highly concentrated at one area of the 
dosimeter as mentioned above it could affect the reading of the TLD and OSLD. In addition, 
the OSLDs were calibrated from standard OSLDs obtained from the manufacturer, but 
ideally should be calibrated to include additional corrections due to fading, angular 
dependences, and beam-quality that could all play a role in the differences identified 
between the results. However, the main use of the OSLDs in our study was to study the 
relationships of the radiation dose with changes in the in vivo measurement, which should 
be consistent regardless of quantification issues.
The phantoms used as a proxy for skin, bone, and toenail in our experimental setup were not 
able to perfectly represent the radiation interactions of real skin, bone, or toenail. Lucite as a 
skin phantom was shown to be spectrally equivalent to cadaver skin in a previous study, but 
even considering this there are slight differences in attenuation and density. Similarly, the 
density and attenuation of plaster-of-Paris is not the same as bone, as discussed in an in-
depth calibration study (Da Silva & Pejovic-Milic, 2017). The toenails were made to match 
attenuation coefficients of the characteristic x-rays of specific metals of interest between 5–
11 keV, as discussed in previous studies, but the attenuation coefficients will vary as the 
energy changes from the energies of interest which will also change the scattering dose (Roy 
et al., 2010; Zhang et al., 2017). These differences will likely reflect an increase in the 
radiation dose from scatter of around 10 to 20% for the phantom measurements in 
comparison to true in vivo measurements due to the increased scatter cross sections for the 
phantoms. Considering the majority of the dose likely arises from direct interaction with the 
initial x-ray beam and the use of phantoms showed minimal increase in dose, we can accept 
these measurements and relationships to be slightly more conservative than true in vivo dose 
measurements. The simulation used accurately depicted human compositional and density 
data and included a life-size human leg for total body effective dose quantification, so 
simulation results should be the most accurate in terms of comparisons to radiation dose 
experienced in a true in vivo measurement.
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Using the total body effective dose, we can estimate the risk of radiation-induced cancers. 
The increased risk for cancer and other inheritable effects from radiation has been found to 
be 5% per Sievert of total body effective dose (ICRP., 2007). Given the doses we found form 
the 3-minute portable XRF measurement, this would mean a 0.000004%, 0.000003%, and 
0.000002% increased risk of cancer for 5-year olds, 10-year olds, and adults (ICRP., 2007).
Deterministic effects from skin dose have been shown to occur for doses in excess of 2 Gy 
according to ICRP publication 85, which the portable XRF skin dose is 400 times less than 
(ICRP., 2000). This 2 Gy limit for skin doses is typically assigned assuming a uniform dose 
to an area; however, studies in radiation therapy patients have shown that when doses are 
limited to small areas, stem cells migrate from surrounding unaffected skin to repopulate the 
areas affected by DNA damage.(von Essen, 1969; Withers, 1967) More recent studies have 
shown this to increase the resiliency of normal tissues by up to a factor of 4, which in the use 
of the portable XRF would further reduce the unlikely possibility of deterministic skin 
damage due to the small radiation beam used for measurements.(Narayanasamy et al., 2017)
Given the minimal skin dose and total body effective dose associated with these 
measurements, even measurement times as high as 10-minutes could be considered while 
maintaining a reasonable limit for exposure. The limit for total body effective dose to any 
member of the public set by NRC CFR 20.1301 is at 1 mSv per year, which is 100–300 
times more than given in a single 3-minute measurement from our device.
The total body effective dose measurements shown in Table 2 were taken as the highest dose 
considering differences in sex. We only had sex specific data for total body bone area, and 
were not able to find sex specific data for skin area. The dose difference between males and 
females was minor with the greatest difference in the adult calculation of total body effective 
dose of 2.9 uSv for males and 3.4 uSv for females. Ten-year-old males had higher dose due 
to lower total bone area, since females typically have more growth earlier than males due to 
puberty. Almost all of the total body effective dose arose from the absorbed dose in the 
surface of the bone.
The surface bone dose decreases slightly in relation to the overlying tissue thickness, and 
detection accuracy for in vivo metal measurements decreases with increasing skin thickness. 
For in vivo measurement, typically there is a tradeoff between accuracy of the measurement 
and radiation dose (Aaron James Specht et al., 2014). As the surface bone dose decreases, so 
does the signal that arises from the bone, which in-turn increases the uncertainty of the metal 
quantification measurement. In our previous study, we found 3-minute measurements with 
50 kV and 40 uA would achieve reasonable detection limits for populations with skin 
thickness lower than 5 mm (Aaron James Specht et al., 2014). In further application of the 
device, we found this to be a less reasonable assumption for all populations (A. J. Specht et 
al., 2016). With the results shown here, it seems that longer measurement times of up to 10 
minutes would be feasible while maintaining acceptable radiation dose limits. This would 
reduce the detection limit by a factor of the square root of the increase in time or current, 
which in this case would be a decrease of a factor 1.8. However, we need to make sure the 
increased measurement times would not be overexposing those with low tissue thickness in 
order to capture a greater proportion of the population. Our results indicate that the dose 
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change for individuals with lower soft tissue thicknesses is relatively minor with an increase 
of about 0.8 uSv total body effective dose from 5 mm to 1 mm tissue thickness for a 3-
minute measurement. The detection limit change over this tissue thickness difference is 
much more drastic with a detection limit of 11.0 and 1.8 ppm for 5 and 1 mm tissue 
thickness respectively (Aaron James Specht et al., 2014). This demonstrates that the primary 
limiting factors of the detection limit of the measurement come from a combination of the 
absolute efficiency of the detector, which decreases with the inverse square law from 
increasing tissue thickness, and the added attenuation from soft tissue thickness. The inverse 
square drop off with distance is a result of the characteristic x-ray production in the bone 
being isotropic, which will greatly decrease the efficiency of the detector with increasing 
distance from the characteristic x-rays arising in the bone. The added attenuation is a larger 
factor for the outgoing x-ray signal, since the initial x-ray beam is of higher average energy 
than the characteristic x-ray signal. Thus, the x-ray signal would have a higher interaction 
cross-section and probability of attenuation with increases in tissue thickness. Although our 
results indicate the radiation dose and total number of interactions creating signal in the 
bone will change, that relationship is almost linear over the range of tissue thicknesses in 
general population, and will have limited impact on increases in the detection limit in 
comparison to the changes induced by the inverse square effect and outgoing signal 
attenuation.
5. Conclusion
This study looked at the radiation dose administered while taking in vivo metal 
measurements with a standard 2-watt silver x-ray tube. We showed normal linear 
relationships between measurement time, x-ray tube current, and radiation dose with the 
device, and showed a second order polynomial relationship with increasing voltage and 
radiation dose. Dose was quantified using TLD, OSLD, and simulations, which gave similar 
dose estimations. Skin dose for a standard 50 kV 40 uA measurement for bone and toenail in 
vivo was 48.5 and 28.7 mSv according to simulation results. Total body effective dose was 
shown as 3.4 and 2.0 uSv for in vivo bone and toenail measurements for adults using the 
portable XRF device with a 3-minute measurement.
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Figure 1. 
Radiation entrance skin dose (0.2 cm2) changes with different measurement times using 50 
kV 40 uA and silver and iron filtration.
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Figure 2. 
Radiation entrance skin dose (0.2 cm2) changes with different x-ray tube voltage settings 
using 40 uA and silver and iron filtration.
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Figure 3. 
Radiation entrance skin dose (0.2 cm2) changes with different x-ray tube voltage settings 
using 40 uA and molybdenum and iron filtration.
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Figure 4. 
Radiation entrance skin dose (0.2 cm2) changes with different x-ray tube voltage settings 
using 40 uA and aluminum and titanium filtration.
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Figure 5. 
Radiation entrance skin dose (0.2 cm2) changes with different x-ray tube current settings 
using 40 kV and silver and iron filtration.
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Figure 6. 
Bone surface dose changes with increasing thickness of skin over bone using 50 kV, 40 uA, 
and silver and iron filtration.
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Table 1.
Skin dose to 0.2 cm2 with measurements of bone and toenail in vivo measurements.
Dose Measurements
(mSv)
Measurement
5mm Skin
with Bone
1.3 mm
Toenail
1 73.9 67.9
2 60.2 61.7
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Table 2.
Skin, bone, and total body effective dose for bone and toenail portable XRF measurements.
Total Body Effective Dose (uSv)
Bone
Measurement
Toenail
Measurement
5-year-old 7.4 4.4
10-year-old 4.9 2.9
Adult 3.4 2.0
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Table 3.
Skin dose measurements for in vivo portable XRF measurements using different measurement techniques.
Dose Estimates (mSv)
TLD
(0.2 cm2)
TLD
(~0.8 cm2)
OSLD
(0.2 cm2)
Simulation
(1 cm2)
Bone
Measurement 73.9 48.8 103.7 48.5
Toenail
Measurement 67.9 43.3 111.7 28.7
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